A detailed history of Fairtree Asset Management (Pty) LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fairtree Asset Management (Pty) LTD holds 8,011 shares of MRK stock, worth $673,404. This represents 0.58% of its overall portfolio holdings.

Number of Shares
8,011
Holding current value
$673,404
% of portfolio
0.58%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$83.01 - $101.02 $664,993 - $809,271
8,011 New
8,011 $719 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $213B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Fairtree Asset Management (Pty) LTD Portfolio

Follow Fairtree Asset Management (Pty) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairtree Asset Management (Pty) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairtree Asset Management (Pty) LTD with notifications on news.